Mathematical models of lipoprotein metabolism and kinetics: current status and future perspective
暂无分享,去创建一个
[1] M. Krempf,et al. New model for kinetic studies of HDL metabolism in humans , 2004, European journal of clinical investigation.
[2] Samia Mora,et al. A comparison of the theoretical relationship between HDL size and the ratio of HDL cholesterol to apolipoprotein A-I with experimental results from the Women's Health Study. , 2013, Clinical chemistry.
[3] Samuel Kaski,et al. High Density Lipoprotein Structural Changes and Drug Response in Lipidomic Profiles following the Long-Term Fenofibrate Therapy in the FIELD Substudy , 2011, PloS one.
[4] Daniël B. van Schalkwijk,et al. Diagnostic markers based on a computational model of lipoprotein metabolism , 2011, Journal of Clinical Bioinformatics.
[5] A. Zwinderman,et al. Lipidomic approach to evaluate rosuvastatin and atorvastatin at various dosages: investigating differential effects among statins , 2008, Current medical research and opinion.
[6] T Magot,et al. A new labeling approach using stable isotopes to study in vivo plasma cholesterol metabolism in humans. , 2002, Metabolism: clinical and experimental.
[7] Friedrich C. Luft,et al. A pathway model of lipid metabolism to predict the effect of genetic variability on lipid levels , 2000, Journal of Molecular Medicine.
[8] A. Kontush,et al. Lipidomics as a Tool for the Study of Lipoprotein Metabolism , 2010, Current atherosclerosis reports.
[9] P Hugh R Barrett,et al. Thematic Review What We Have Learned about Vldl and Ldl Metabolism from Human Kinetics Studies , 2022 .
[10] Hiroaki Kitano,et al. CellDesigner: a process diagram editor for gene-regulatory and biochemical networks , 2003 .
[11] P Hugh R Barrett,et al. Thematic review series: Patient-Oriented Research. Design and analysis of lipoprotein tracer kinetics studies in humans Published, JLR Papers in Press, May 25, 2006. , 2006, Journal of Lipid Research.
[12] Jacob D. Durrant,et al. Molecular dynamics simulations and drug discovery , 2011, BMC Biology.
[13] P. Meikle,et al. Lipidomics is providing new insight into the metabolic syndrome and its sequelae , 2011, Current opinion in lipidology.
[14] M. Berman,et al. Multicompartmental analysis of cholesterol metabolism in man. Quantitative kinetic evaluation of precursor sources and turnover of high density lipoprotein cholesterol esters. , 1982, The Journal of clinical investigation.
[15] Jianwen Fang,et al. Structure of apolipoprotein A-I in spherical high density lipoproteins of different sizes , 2008, Proceedings of the National Academy of Sciences.
[16] Ph.D. James E. A. McIntosh M.A.,et al. Mathematical Modelling and Computers in Endocrinology , 1980, Monographs on Endocrinology.
[17] Jeffrey H. Chuang,et al. Dynamic simulation of cardiolipin remodeling: greasing the wheels for an interpretative approach to lipidomics[S] , 2010, Journal of Lipid Research.
[18] D. Rader,et al. The effect of PPAR-alpha agonism on apolipoprotein metabolism in humans. , 2010, Atherosclerosis.
[19] G. Lewis,et al. Thematic review series: Patient-Oriented Research. What have we learned about HDL metabolism from kinetics studies in humans? Published, JLR Papers in Press, May 9, 2006. , 2006, Journal of Lipid Research.
[20] Hermann-Georg Holzhütter,et al. Computational Lipidology: Predicting Lipoprotein Density Profiles in Human Blood Plasma , 2008, PLoS Comput. Biol..
[21] C Cobelli,et al. SAAM II: Simulation, Analysis, and Modeling Software for tracer and pharmacokinetic studies. , 1998, Metabolism: clinical and experimental.
[22] Charles C Schwartz,et al. Lipoprotein cholesteryl ester production, transfer, and output in vivo in humans Published, JLR Papers in Press, May 16, 2004. DOI 10.1194/jlr.M300511-JLR200 , 2004, Journal of Lipid Research.
[23] Ilpo Vattulainen,et al. Role of Lipids in Spheroidal High Density Lipoproteins , 2010, PLoS Comput. Biol..
[24] D. Rader,et al. Targeting High Density Lipoproteins in the Prevention of Cardiovascular Disease? , 2012, Current Cardiology Reports.
[25] Sven Sahle,et al. Computational modeling of biochemical networks using COPASI. , 2009, Methods in molecular biology.
[26] A. D. de Graaf,et al. Clustering by Plasma Lipoprotein Profile Reveals Two Distinct Subgroups with Positive Lipid Response to Fenofibrate Therapy , 2012, PloS one.
[27] F. Tobin,et al. Mechanism of inhibition defines CETP activity: a mathematical model for CETP in vitro , 2009, Journal of Lipid Research.
[28] Darren J. Wilkinson,et al. A whole-body mathematical model of cholesterol metabolism and its age-associated dysregulation , 2012, BMC Systems Biology.
[29] A. D. de Graaf,et al. Computational models for analyzing lipoprotein profiles , 2011 .
[30] Sven Sahle,et al. Applications and trends in systems biology in biochemistry , 2011, The FEBS journal.
[31] Matej Oresic,et al. Exploring the lipoprotein composition using Bayesian regression on serum lipidomic profiles , 2007, ISMB/ECCB.
[32] Ben van Ommen,et al. A physiologically based in silico kinetic model predicting plasma cholesterol concentrations in humans[S] , 2012, Journal of Lipid Research.
[33] D. H. Gregory,et al. Multicompartmental analysis of cholesterol metabolism in man. Characterization of the hepatic bile acid and biliary cholesterol precursor sites. , 1978, The Journal of clinical investigation.
[34] S. Nicholls,et al. The emerging role of plasma lipidomics in cardiovascular drug discovery , 2012, Expert opinion on drug discovery.
[35] B. Shen,et al. Structure of human serum lipoproteins inferred from compositional analysis. , 1977, Proceedings of the National Academy of Sciences of the United States of America.
[36] L. Curtiss,et al. Apolipoprotein A-I structural organization in high density lipoproteins isolated from human plasma , 2010, Nature Structural &Molecular Biology.
[37] S. Turner,et al. Measurement of Reverse Cholesterol Transport Pathways in Humans: In Vivo Rates of Free Cholesterol Efflux, Esterification, and Excretion , 2012, Journal of the American Heart Association.
[38] S. Hazen,et al. The Low Resolution Structure of ApoA1 in Spherical High Density Lipoprotein Revealed by Small Angle Neutron Scattering* , 2011, The Journal of Biological Chemistry.
[39] Markus Abt,et al. Effects of dalcetrapib in patients with a recent acute coronary syndrome. , 2012, The New England journal of medicine.